Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.
In this month’s Medtech Talk, co-host Swaril Mathur, former vice president of business development at Axonics, debuts in her first episode with John Woock, former EVP and chief marketing and strategy officer at Axonics. They discuss the early days of their previous company, including what motivated Woock to join a company that was considered risky at the time, what he learned from supporting and working directly with the field team, and how Axonics handled the early stages of commercial launch during the pandemic. Woock also reflects on how much the company has changed over the years in its culture and leadership, including the decisions that felt good and the ones that were harder to grapple with..
GUEST BIO
John Woock, Former EVP, Chief Marketing and Strategy Officer at Axonics
John Woock is a medtech executive with deep expertise and a proven track record of building successful commercial strategies for innovative medical device companies. He was Executive Vice President and Chief Marketing & Strategy Officer at Axonics, which was acquired by Boston Scientific for $3.7B in 2024. At Axonics, he was integral to product design efforts, oversaw clinical trials in Europe and the United States, and eventually led the company’s 500-person commercial operations. Woock is an alumni of McKinsey & Company and the Stanford Biodesign Innovation Program. He holds a PhD from Duke University, focused on neuromodulation.
HOST BIO
Swaril Mathur, Former Vice President of Business Development, AxonicsSwaril Mathur is a strategic growth leader with deep expertise in building and scaling transformative medical technologies through early-stage innovation, M&A, and go-to-market execution. Most recently, as Former Vice President of Business Development at Axonics, she led M&A and strategic initiatives, including the company’s $3.7B acquisition by Boston Scientific. Prior to joining Axonics, Swaril drove early-stage innovation at Edwards Lifesciences as a member of the Advanced Technology group, and at Stanford University as a Biodesign Innovation Fellow. In these roles, she partnered with engineers and physicians to identify and address unmet clinical needs in cardiology and otolaryngology. She remains actively involved with Stanford Biodesign, currently co-teaching its Global Faculty Training program, which equips international leaders to support needs-driven healthcare innovation in their home countries.
Swaril began her career at Boston Consulting Group, supporting strategic transformations and business integrations for leading healthcare clients. She holds an M.S. in Bioengineering from Stanford University and a B.S. in Biomedical Engineering from the University of California, Irvine.
